First and only PARP inhibitor to improve overall survival in early breast cancer
Third Phase 3 trial in third type of lymphoma to show improvement in overall survival with an ADCETRIS-containing regimen
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
Subscribe To Our Newsletter & Stay Updated
